Elisabeth Bendstrup

How does comorbidity influence survival in idiopathic pulmonary fibrosis?

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

How does comorbidity influence survival in idiopathic pulmonary fibrosis? / Hyldgaard, Charlotte; Hilberg, Ole; Bendstrup, Elisabeth.

In: Respiratory Medicine, 02.02.2014.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{7061fd983a2c4df68c2baf35ddce8577,
title = "How does comorbidity influence survival in idiopathic pulmonary fibrosis?",
abstract = "Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It is a serious and progressive lung disease with a median survival of three years. The role of comorbidities in the prognosis of IPF is not clear.",
author = "Charlotte Hyldgaard and Ole Hilberg and Elisabeth Bendstrup",
note = "Copyright {\textcopyright} 2014 Elsevier Ltd. All rights reserved.",
year = "2014",
month = feb,
day = "2",
doi = "10.1016/j.rmed.2014.01.008",
language = "English",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "Elsevier Ltd",

}

RIS

TY - JOUR

T1 - How does comorbidity influence survival in idiopathic pulmonary fibrosis?

AU - Hyldgaard, Charlotte

AU - Hilberg, Ole

AU - Bendstrup, Elisabeth

N1 - Copyright © 2014 Elsevier Ltd. All rights reserved.

PY - 2014/2/2

Y1 - 2014/2/2

N2 - Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It is a serious and progressive lung disease with a median survival of three years. The role of comorbidities in the prognosis of IPF is not clear.

AB - Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It is a serious and progressive lung disease with a median survival of three years. The role of comorbidities in the prognosis of IPF is not clear.

U2 - 10.1016/j.rmed.2014.01.008

DO - 10.1016/j.rmed.2014.01.008

M3 - Journal article

C2 - 24529739

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

ER -